glyburide has been researched along with Diabetic Glomerulosclerosis in 22 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Troglitazone, a newly developed thiazolidinedione derivative, has been shown to ameliorate microalbuminuria in diabetic animal model and in human diabetic nephropathy in short-term studies." | 9.09 | Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria. ( Ebihara, L; Koide, H; Nakamura, T; Sekizuka, K; Shimada, N; Suzuki, S; Ushiyama, C, 2001) |
| "Troglitazone, a newly developed thiazolidinedione derivative, has been shown to ameliorate microalbuminuria in diabetic animal model and in human diabetic nephropathy in short-term studies." | 5.09 | Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria. ( Ebihara, L; Koide, H; Nakamura, T; Sekizuka, K; Shimada, N; Suzuki, S; Ushiyama, C, 2001) |
| "Hypoglycemia is common in patients with diabetes." | 1.48 | Risk of Hypoglycemia Following Hospital Discharge in Patients With Diabetes and Acute Kidney Injury. ( Abdel-Kader, K; Greevy, RA; Griffin, MR; Horner, J; Hung, AM; Ikizler, TA; Matheny, ME; Parr, SK; Perkins, AM; Roumie, CL; Siew, ED; Speroff, T; Wilson, OD, 2018) |
| "Diabetic nephropathy is one of the important microvascular complications of diabetes; however, the main problem remains is the control of progression of nephropathy in diabetes." | 1.39 | Chebulic acid attenuates ischemia reperfusion induced biochemical alteration in diabetic rats. ( Gupta, VB; Silawat, N, 2013) |
| "Gliclazide treatment, but not glibenclamide, significantly reduced the oxidative products and NAD(P)H oxidase." | 1.32 | Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet. ( Fujita, T; Goto, A; Onozato, ML; Tojo, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Elbassuoni, EA | 1 |
| Аziz, NM | 1 |
| Habeeb, WN | 1 |
| Saberi, M | 1 |
| Ramazani, Z | 1 |
| Rashidi, H | 1 |
| Saberi, A | 1 |
| Hung, AM | 1 |
| Siew, ED | 1 |
| Wilson, OD | 1 |
| Perkins, AM | 1 |
| Greevy, RA | 1 |
| Horner, J | 1 |
| Abdel-Kader, K | 1 |
| Parr, SK | 1 |
| Roumie, CL | 1 |
| Griffin, MR | 1 |
| Ikizler, TA | 1 |
| Speroff, T | 1 |
| Matheny, ME | 1 |
| Süfke, S | 1 |
| Steinhoff, J | 1 |
| Schütt, M | 1 |
| Douros, A | 1 |
| Ebert, N | 1 |
| Jakob, O | 1 |
| Martus, P | 1 |
| Kreutz, R | 1 |
| Schaeffner, E | 1 |
| Rodríguez-Villar, C | 1 |
| Conget, I | 1 |
| Ferrer-Fàbrega, J | 1 |
| Paredes, D | 1 |
| Ruíz, A | 1 |
| Roque, R | 1 |
| Rull, R | 1 |
| López-Boado, M | 1 |
| Ricart, MJ | 1 |
| Garcia, R | 1 |
| Adalia, R | 1 |
| Esmatjes, E | 1 |
| Jimenez, A | 1 |
| Diaz, G | 1 |
| Mora, M | 1 |
| Casamitjana, R | 1 |
| Pérez de Nanclares, G | 1 |
| Castaño, L | 1 |
| José Ricart, M | 1 |
| Ramkumar, KM | 1 |
| Ponmanickam, P | 1 |
| Velayuthaprabhu, S | 1 |
| Archunan, G | 1 |
| Rajaguru, P | 1 |
| Lachin, JM | 1 |
| Viberti, G | 1 |
| Zinman, B | 1 |
| Haffner, SM | 1 |
| Aftring, RP | 1 |
| Paul, G | 1 |
| Kravitz, BG | 1 |
| Herman, WH | 1 |
| Holman, RR | 1 |
| Kahn, SE | 1 |
| Silawat, N | 1 |
| Gupta, VB | 1 |
| Zhu, L | 1 |
| Cortes, P | 2 |
| Hassett, C | 2 |
| Taube, DW | 2 |
| Yee, J | 2 |
| Akbar, DH | 1 |
| Hagras, MM | 1 |
| Amin, HA | 1 |
| Khorshid, OA | 1 |
| Omori, Y | 1 |
| Onozato, ML | 1 |
| Tojo, A | 1 |
| Goto, A | 1 |
| Fujita, T | 1 |
| Stiefelhagen, P | 1 |
| Giannico, G | 1 |
| Baccora, MH | 1 |
| Roberge, RJ | 1 |
| Kaplan, R | 1 |
| Frank, R | 1 |
| Fore, C | 1 |
| Nakamura, T | 1 |
| Ushiyama, C | 1 |
| Suzuki, S | 1 |
| Shimada, N | 1 |
| Sekizuka, K | 1 |
| Ebihara, L | 1 |
| Koide, H | 1 |
| Reddi, AS | 3 |
| Oppermann, W | 2 |
| Velasco, C | 1 |
| Camerini-Davalos, RA | 3 |
| Ehrenreich, TH | 1 |
| Strugatz, LH | 1 |
| Haslbeck, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed [NCT00279045] | Phase 3 | 4,426 participants (Actual) | Interventional | 2000-01-03 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for glyburide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
[Medical management of pregnant women with diabetes].
Topics: Blood Glucose; Body Weight; Congenital Abnormalities; Diabetic Nephropathies; Diabetic Retinopathy; | 2002 |
[New aspects of therapy with oral antidiabetic agents].
Topics: Acidosis; Biguanides; Blood Proteins; Chlorpropamide; Diabetes Mellitus; Diabetic Nephropathies; Dru | 1979 |
2 trials available for glyburide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diab | 2011 |
Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria.
Topics: Albuminuria; Animals; Blood Pressure; Chromans; Collagen; Creatinine; Diabetes Mellitus, Type 2; Dia | 2001 |
18 other studies available for glyburide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
The role of activation of K
Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Diabetes Mellitus, Experimental; Diabetic | 2020 |
The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy.
Topics: Biomarkers; Blood Glucose; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Diabetic Nephropathie | 2020 |
Risk of Hypoglycemia Following Hospital Discharge in Patients With Diabetes and Acute Kidney Injury.
Topics: Acute Kidney Injury; Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Nephropathies; Female; | 2018 |
[Diabetes treatment in patients with chronic kidney disease].
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Substitution; Drug Therapy, Combinatio | 2013 |
Estimating kidney function and use of oral antidiabetic drugs in elderly.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Biomarkers; Creatinine; Cross-Sectional | 2015 |
Successful Pancreas Transplantation From a Deceased Donor Intoxicated With Oral Antidiabetic Agent: A Case Report.
Topics: Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Overdose; Female; Glyburide; Humans; Hypogly | 2015 |
Neonatal diabetes with end-stage nephropathy: pancreas transplantation decision.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Glyburide; Humans; Hypo | 2008 |
Protective effect of Gymnema montanum against renal damage in experimental diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephrop | 2009 |
Chebulic acid attenuates ischemia reperfusion induced biochemical alteration in diabetic rats.
Topics: Animals; Benzopyrans; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relatio | 2013 |
Glibenclamide induces collagen IV catabolism in high glucose-stimulated mesangial cells.
Topics: Animals; Cells, Cultured; Collagen Type IV; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabet | 2012 |
Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Creatinine; Diabetic Nephropathies; | 2013 |
Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet.
Topics: Animals; Blood Pressure; Cholesterol, Dietary; Diabetes Mellitus, Experimental; Diabetic Nephropathi | 2004 |
[Nothing here follows protocol F. Elderly diabetic patients are not "DMP qualified"].
Topics: Aged; Blood Glucose; Comorbidity; Contraindications; Diabetes Mellitus, Type 2; Diabetic Foot; Diabe | 2005 |
Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells.
Topics: Actins; Animals; Biological Transport, Active; Cells, Cultured; Collagen Type I; Collagen Type IV; C | 2007 |
Glyburide-ciprofloxacin interaction with resistant hypoglycemia.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic N | 2000 |
Diabetic microangiopathy in KK mice. V. Effect of early glyburide treatment of kidney glucosyltransferase activity.
Topics: Animals; Blood Glucose; Diabetic Angiopathies; Diabetic Nephropathies; Glucosyltransferases; Glyburi | 1978 |
Diabetic glomerulosclerosis in KK mice and its prevention by glyburide and pyridinolcarbamate.
Topics: Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose | 1979 |
Kidney disease in KK mice: effect of glyburide.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephrop | 1988 |